Athenex, Inc.
ATNX
|
NASDAQ
|
0 Sledující
Company Quality
Profitability Score
18/100
Solvency Score
27/100
Dividends
Dividends data currently unavailable.Earnings
Earnings data currently unavailable.My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Drug Manufacturers - Specialty & Generic
Průmysl
Dr. Yiu-Nam Lau F.R.C.P., M.B.B.S., M.D., Ph.D.
CEO
269
Zaměstnanci
Buffalo
Centrála
US
Země
Key Metrics TTM
Valuation
Market cap.
$2.3MEnterprise Value
$9.1MPrice to Earnings
-0.01Price to Sales
0.02Price to Book
-0.20Price to Cash Flow
-0.03Profitability
Return on Assets
-48.50%Return on Equity
21.51%Return on Invested Capital
-54.66%Gross Margin
25.97%Operating Margin
-68.02%Net Margin
-96.26%Liquidity
Quick Ratio
0.72Current Ratio
1.09Cash Ratio
0.31Inventory Turnover
1.78Asset Turnover
0.50Total Liabilities
$204MSolvency
Debt to Assets
0.21Debt to Equity
N/AInterest Coverage
-2.71Equity Ratio
0.00Long-term Debt to Cap.
-0.94Altman Z-Score
-7.52Performance
Performance data currently unavailable.
Earnings Waterfall
Debt level and coverage
Debt level and coverage data currently unavailable.
Earnings
Feed
There are no posts to show right now.